Research Pipeline
Research Pipeline
Research & Development
Our R&D engine has both internal research capabilities and external partnerships is expected to deliver a steady stream of next-generation developments that will sustain our growth. These programs leverage new platform capabilities in multi-omics, data sciences, and more.
As you can see from our current research pipeline, there’s a lot happening behind the scenes at TruDiagnostic — and a lot to look forward to.
Our Research Timeline
Active Studies
Estimated Completion Date: August 2021
Principle Investigator: Dr. Edwin Lee, MD
Estimated Completion Date: August 2021
Principle Investigator: Dr. Hector Lopez, MD, CSCS, FAAPMR
Estimated Completion Date: December 2021
Principle Investigator: Dr. Tavis Mendez, PhD
Estimated Completion Date: December 2021
Principle Investigator: Dr. Tavis Mendez, PhD
Estimated Completion Date: September 2022
Principle Investigator: Dr. Jessica Lasky-Su
Estimated Completion Date: June 2022
Principle Investigator: Dr. Vincent Giampapa MD, FACS
Estimated Completion Date: November 2022
Principle Investigator: Dr. Tavis Mendez, Ph.D.
Estimated Completion Date: July 2022
Principle Investigator: Dr. Anthony Maffei
Estimated Completion Date: December 2021
Principle Investigator: Dr. Julie Kissel, MD
Study Sponsor: QuickSilver
Estimated Completion Date: June 2022
Principle Investigator: Dr. Sanjeev Goel, MD
Study Sponsor: TruDiagnostic LLC, Peak Human Labs
Estimated Completion Date: August 2021
Principle Investigator: Dr. Tavis Mendez, PhD
Study Sponsor: TruDiagnostic LLC
Estimated Completion Date: November 2021
Principle Investigator: Dr. James Foster
Study Sponsor: Preventative Medicine Research Group
Estimated Completion Date: March 2022
Principle Investigator: Dr. Phillip Gallegos, MD
Study Sponsor: Optigenex, Inc.
Estimated Completion Date: February 2022
Principle Investigator: Dr. Juergen Winkler, MD
Study Sponsor: Extended Longevity. Inc.